Status:
UNKNOWN
Intrathecal Morphine and Fentanyl for Knee Arthroplasty
Lead Sponsor:
Keimyung University Dongsan Medical Center
Conditions:
Knee Arthroplasty
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
This study is planned to investigate the efficacy of combined infusion of intrathecal morphine and fentanyl in patients undergoing total knee arthroplasty.
Eligibility Criteria
Inclusion
- Patients scheduled total knee replacement under spinal anesthesia
- ASA I-III
Exclusion
- Coagulopathy
- Heart disease
- Liver disease
- Kidney disease
- Infection
- Psychological disorder
- Allergy to bupivacaine
- Allergy to morphine
- Allergy to fentanyl
- Inability to use patient-controlled analgesic device
- Opioids due to chronic pain
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT03365115
Start Date
January 1 2018
End Date
February 1 2019
Last Update
December 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.